Written by Smartech Daily Team
This article has been originally published on Smartech Daily and republished at Dataconomy with permission.
(Picture Above: Xenco Medical Founder and CEO Jason Haider illustrated above. Illustration by Claudia Emmaneul.)
Between the thrum of live music, immersive tech showcases, and celebrity-packed panels, healthcare didn’t just quietly show up at SXSW 2026, it made waves in a way that felt both inevitable and entirely new. What was once a niche track tucked between more headline-grabbing industries has evolved into a central pillar of the festival, reflecting a broader cultural shift: health is no longer confined to hospitals, research labs, or policy debates. It is personal, social, technological, and increasingly, it is front and center. At SXSW this year, the patient experience was reshaped again when Xenco Medical unveiled XenForge 3D, a platform that signals a decisive shift toward fully integrated, engagement-driven care delivery at one of the most buzzworthy innovation events of the weeklong festival in Austin.
At its core, XenForge 3D is not simply about 3D printing or surgical planning, it is about strategically transforming how patients understand, participate in, and move through the entire continuum of care.
XenForge’s 3D-printed patient-specific models drive non-diagnostic engagement, serving as a bridge between complex clinical data and human understanding. This positions the platform as a foundational layer in a broader ecosystem, one that seamlessly connects preoperative education, intraoperative precision, and postoperative recovery.
Building technologies that bring a systems-thinking approach for ecosystems of care is not new for the trailblazing company. Rather, XenForge 3D represents the front-end evolution of a continuum Xenco Medical has already been building, most notably through its TrabeculeX Continuum, a platform that integrates biomaterial implantation with digital rehabilitation and remote monitoring.
We sat down with Founder and CEO Jason Haider to explore how these technologies come together to redefine the patient journey.
XenForge was one of the most talked-about unveilings at SXSW. What core problem are you solving with this platform? How does it fit into Xenco Medical’s broader continuum-of-care strategy?
Jason Haider: XenForge 3D is very intentionally designed as the entry point into a continuous care ecosystem. If you look at healthcare historically, each phase, diagnosis, surgery, recovery, has operated in isolation. What we’ve been building at Xenco Medical is a system that dissolves those boundaries.
With XenForge 3D, we transform the very first interaction a patient has with their condition. By converting imaging data into a non-diagnostic, life-scale 3D model, we create an immediate, intuitive understanding of anatomy and pathology. That becomes the foundation for engagement.
But that’s only the beginning. What makes XenForge 3D strategically powerful is that it connects directly into the rest of the continuum, particularly our TrabeculeX Continuum platform, which extends engagement into the postoperative phase.
So instead of engagement being a moment, it becomes a longitudinal experience, one that starts with understanding and continues through healing.
Can you explain how XenForge 3D and the TrabeculeX Continuum complement each other across that journey?
Jason Haider: Absolutely. XenForge 3D operates at the preoperative and intraoperative interface, while the TrabeculeX Continuum extends that engagement into postoperative recovery and rehabilitation. The TrabeculeX Continuum is designed as a bridge between orthobiologics and digital health, combining a regenerative biomaterial, the TrabeculeX Bioactive Matrix, with a digital recovery platform that enables remote monitoring and personalized rehabilitation. When each of our surgeons implant the regenerative biomaterial, the patient is enrolled into the TrabeculeX Recovery App, where their AI-driven rehabilitation is guided, monitored, and continuously optimized. The system allows for asynchronous communication, real-time feedback, and adaptive therapy protocols.
Now, when you connect that to XenForge 3D, you create something fundamentally different in that pre-operatively, the patient understands their anatomy through their own reconstructed physical model, intraoperatively, they benefit from personalized implant configurations and single-use instrumentation, and post-operatively, they remain actively engaged through a digitally connected rehabilitation ecosystem. This is what we mean by treating the entire continuum of care, not as separate phases, but as a unified, orchestrated experience.
How does this continuous engagement model impact patient outcomes and behavior?
Jason Haider: Engagement is one of the most underutilized drivers of outcomes in healthcare. When patients understand their condition and feel connected to their care, they behave differently, they adhere more closely to rehabilitation protocols, they communicate more effectively with their providers, and they take ownership of their recovery.
The TrabeculeX Continuum is designed to reinforce that behavior. Through the Recovery App, patients are not just following instructions, they are interacting with their care in real time. The platform captures functional data, such as range of motion, and uses that to continuously adapt rehabilitation plans.
We’ve seen that patients engage with the platform consistently, on average, interacting for minutes each day, which reflects a sustained level of involvement in their recovery. When you combine that with the upfront engagement enabled by XenForge 3D, you create a closed-loop system where understanding leads to participation, and participation drives outcomes.
Strategically, how does this align with value-based care and CMS’s episode accountability model?
Jason Haider: Value-based care requires providers to take responsibility for the entire episode, from preoperative preparation through postoperative recovery. That means you need systems that don’t just optimize individual steps, but connect them.
XenForge 3D and the TrabeculeX Continuum together create that connection. XenForge 3D ensures that patients enter the episode with clarity and alignment. The surgical system, our single-use, sterile packaged implants, ensures consistency and efficiency during the procedure. And the TrabeculeX Continuum ensures that recovery is actively managed and continuously monitored.
This directly addresses one of the biggest challenges in healthcare: the disconnect between surgery and rehabilitation. By bridging that gap, we reduce variability, improve predictability, and ultimately lower the total cost of care.
How does this reflect Xenco Medical’s broader philosophy and legacy of innovation?
Jason Haider: Everything we’ve done as a company has been focused on eliminating variability and improving outcomes. Our single-use, sterile packaged systems were designed to remove the inconsistencies and risks associated with reusable instruments, ensuring that every patient is treated with a system performing at its peak condition. Our biomimetic implants were designed to more closely replicate natural bone structure and promote regeneration.
And now, with XenForge 3D and the TrabeculeX Continuum, we’re extending that same philosophy into the experience of care itself. We’re engineering not just better tools, but better journeys, where every phase is connected, every interaction is meaningful, and every patient is engaged.
Looking ahead, what does this fully integrated continuum enable that wasn’t possible before?
Jason Haider: What it enables is true continuity. For the first time, we can connect understanding, intervention, and recovery into a single, data-driven ecosystem. Traditionally, healthcare has been episodic. You come in for surgery, and then you leave and manage recovery largely on your own. What we’re building is a system where that fragmentation disappears.
With XenForge 3D and the TrabeculeX Continuum, the patient is continuously supported, from the moment they first understand their anatomy to the point where they regain function. That continuity is what ultimately transforms outcomes.
Final Thoughts
At SXSW this year, it was clear that XenForge 3D is not an isolated innovation, it is the front-end expression of Xenco Medical’s larger vision to unify the entire continuum of care. By anchoring the patient journey in a non-diagnostic, educational 3D model, XenForge 3D transforms the way patients first engage with their condition, turning confusion into clarity and passivity into participation. But its true power emerges when viewed in conjunction with the TrabeculeX Continuum, which extends that engagement into the postoperative phase through digital rehabilitation, remote monitoring, and biomaterial-driven healing.
Together, these platforms create a seamless arc, from education to implantation to recovery, eliminating the fragmentation that has long defined surgical care. This integrated approach reflects Xenco Medical’s pioneering legacy in single-use, sterile packaged systems and biomimetic implants, now expanded into a new domain: the engineering of the patient experience itself. In the context of CMS’s episode-based accountability model and the broader shift toward value-based care, this level of integration is transformative. Engagement is no longer a peripheral concept, it is a core infrastructure layer that drives adherence, improves outcomes, and reduces cost.
What XenForge 3D and the TrabeculeX Continuum ultimately demonstrate is that the future of healthcare lies not just in better interventions, but in better-connected journeys, where every phase of care is aligned, every patient is empowered, and every outcome is the result of a system designed to engage as deeply as it treats. In that sense, Xenco Medical is not just building technologies. It is building continuity, and redefining what it means to care for a patient from beginning to end.
